Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 201–300 of 995
Boyd, T. D., Bennett, S. P., Mori, T., Governatori, N., Runfeldt, M., Norden, M., Padmanabhan, J., Neame, P., Wefes, I., Sanchez-Ramos, J., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091471 · Cited by 128
“Conversely, it has also been shown that amyloid plaques form rapidly and then become decorated by microglia [13,14], both resident and bone marrow-derived, suggesting an ability and intention to remove amyloid [15–17].”
BackgroundThe Role and Therapeutic Targeting of α-, β- and γ-Secretase in Alzheimer's Disease
MacLeod, R., Hillert, E.-K., Cameron, R. T., & Baillie, G. S. (2015) · Future Science OA · doi:10.4155/fso.15.9 · Cited by 125
Tampellini, D., Rahman, N., Gallo, E. F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D. M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2292-09.2009 · Cited by 127
“Accumulation and aggregation of A both intracellularly and extracellularly have been associated with neuritic and synaptic pathology (Takahashi et al., 2002; Meyer-Luehmann et al., 2008), and with reductions in synaptic plasticity and levels of synaptic proteins in several models (Selkoe, 2002; Coleman and Yao, 2003;…”
BackgroundHuang, M., Hu, M., Song, Q., Song, H., Huang, J., Gu, X., Wang, X., Chen, J., Kang, T., Feng, X., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03124 · Cited by 127
Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer’s disease
Yi, C., Mei, X., Ezan, P., Mato, S., Matias, I., Giaume, C., & Koulakoff, A. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.63 · Cited by 139
“Second, another characteristic of neuronal damage is the presence of neuritic dystrophies associated with plaques.(1,30)”
BackgroundJacobs, K. R., Lim, C. K., Blennow, K., Zetterberg, H., Chatterjee, P., Martins, R. N., Brew, B. J., Guillemin, G. J., & Lovejoy, D. B. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.015 · Cited by 125
“Additional neuropathological features of AD include activated microglia and reactive astrocytes surrounding plaques (Meyer-Luehmann et al., 2008; Medeiros and LaFerla, 2013).”
BackgroundSubramanian, J., Savage, J. C., & Tremblay, M.-È. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592607 · Cited by 127
“The curvature of neurites across the plaque continues to increase following plaque formation, with damaged neurites appearing in the subsequent days (Tsai et al., 2004; Meyer-Luehmann et al., 2008).”
BackgroundInfluentialMicroglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity
Czirr, E., Castello, N. A., Mosher, K. I., Castellano, J. M., Hinkson, I. V., Lucin, K. M., Baeza-Raja, B., Ryu, J. K., Li, L., Farina, S. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162011 · Cited by 126
“Although microglia are able to take up fibrillar Aβ into endosome-like compartments (Frackowiak et al., 1992; Meyer-Luehmann et al., 2008), they seem inefficient at degrading and removing Aβ deposits from the AD brain (Grathwohl et al., 2009).”
BackgroundMicroglia in Aging and Alzheimer’s Disease: A Comparative Species Review
Edler, M. K., Mhatre-Winters, I., & Richardson, J. R. (2021) · Cells · doi:10.3390/cells10051138 · Cited by 126
Kondo, S., Kohsaka, S., & Okabe, S. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-27 · Cited by 125
“Although previous in vivo imaging studies reported remodeling of synapses after induction of ischemia [24,25] and in neurodegenerative conditions [26,27], long-lasting changes of synapses triggered by peripheral inflammatory responses have not yet been investigated.”
BackgroundTreatment Strategies Targeting Amyloid -Protein
Schenk, D., Basi, G. S., & Pangalos, M. N. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006387 · Cited by 126
“…et al. 2004; Cleary et al. 2005; Lesne et al. 2006; Townsend et al. 2006b; Cheng et al. 2007; Walsh and Selkoe 2007; Klyubin et al. 2008; Shankar et al. 2008) as well as pathology attributable to plaque-associated Ab (Spires et al. 2005; Kuchibhotla et al. 2008; Meyer-Luehmann et al. 2008, 2009).”
BackgroundRapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice
Ramos-Rodriguez, J. J., Pacheco-Herrero, M., Thyssen, D., Murillo-Carretero, M. I., Berrocoso, E., Spires-Jones, T. L., Bacskai, B. J., & Garcia-Alloza, M. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318288a8dd · Cited by 125
Self-citationMechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease
Zhang, Y., Zhao, Y., Zhang, J., & Yang, G. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03121-z · Cited by 131
Microglial priming in Alzheimer’s disease
Li, J.-W., Zong, Y., Cao, X.-P., Tan, L., & Tan, L. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.22 · Cited by 122
“Activated microglia were shown to migrate to newly formed amyloid plaques rapidly (62), indicating that they might transform their shape into an amoeba-like form aiming at Aβ plaque deposits and might contribute to pathology.”
BackgroundKokjohn, T. A., & Roher, A. E. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.03.002 · Cited by 122
“However, in vivo studies on a real-time basis revealed that amyloid plaques rapidly emerge and disappear in Tg mice [65].”
BackgroundVarvel, N. H., Bhaskar, K., Kounnas, M. Z., Wagner, S. L., Yang, Y., Lamb, B. T., & Herrup, K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39716 · Cited by 121
Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease
Heras-Sandoval, D., Pedraza‐Chaverrí, J., & Pérez‐Rojas, J. M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0525-7 · Cited by 135
“microglia are activated and migrate to amyloid deposits early in the pathogenesis of a mouse model of AD [60].”
BackgroundZiegler‐Waldkirch, S., d′Errico, P., Sauer, J., Erny, D., Savanthrapadian, S., Loreth, D., Katzmarski, N., Blank, T., Bartos, M., Prinz, M., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201797021 · Cited by 120
Self-citationThe Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review
Beardmore, R., Hou, R. H., Darekar, A., Holmes, C., & Boche, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210191 · Cited by 135
Ranasinghe, K. G., Verma, P., Cai, C., Xie, X., Kudo, K., Gao, X., Lerner, H., Mizuiri, D., Strom, A., Iaccarino, L., et al. (2022) · eLife · doi:10.7554/elife.77850 · Cited by 118
Therapeutic Strategies for Alzheimer’s Disease
Barten, D. M., & Albright, C. F. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8031-2 · Cited by 134
Mei, X., Ezan, P., Giaume, C., & Koulakoff, A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.001 · Cited by 134
Zhang, X., Cai, Y., Xiong, K., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., & Yan, X. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07017.x · Cited by 108
“shaft diameter (Spires et al., 2005; Meyer-Luehmann et al., 2008; Knafo et al., 2009), whereas axonal dystrophy is characterized by grape-like swelling and rosette-like sprouting (Fiala, 2007).”
BackgroundInfluentialUltrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
El Hajj, H., Savage, J. C., Bisht, K., Parent, M., Vallières, L., Rivest, S., & Tremblay, M.-È. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1473-9 · Cited by 119
Villette, V., Poindessous-Jazat, F., Simon, A., Léna, C., Roullot, E., Bellessort, B., Epelbaum, J., Dutar, P., & Stéphan, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6284-09.2010 · Cited by 119
“This microglial activation contributes to neuronal alterations, including a local loss of dendritic spines and axonal dystrophy, as well as modifications in the functional properties of neurons (Busche et al., 2008; Meyer-Luehmann et al., 2008).”
Wang, A., Das, P., Switzer, R. C., Golde, T. E., & Jankowsky, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5077-10.2011 · Cited by 118
“Amyloid deposits cause physical and functional changes in local neurons that impact long-range communication in the brain (Le et al., 2001; D’Amore et al., 2003; Stern et al., 2004; Tsai et al., 2004; Busche et al., 2008; Kuchibhotla et al., 2008; Meyer-Luehmann et al., 2008).”
BackgroundZuo, L., Hemmelgarn, B. T., Chuang, C.-C., & Best, T. M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/604658 · Cited by 118
Yi, B., Sahn, J. J., Ardestani, P. M., Evans, A. K., Scott, L. L., Chan, J. Z., Iyer, S., Crisp, A., Zuniga, G., Pierce, J. T., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13917 · Cited by 116
“Because Ab is known to be toxic to synapses and to induce a neuroinflammatory response (Shankar et al. 2007; Halle et al. 2008; Meyer-Luehmann et al. 2008; Koffie et al. 2009), we determined whether SAS-0132 affects synaptic pathology and the neuroinflammatory response.”
Dhawan, G., & Combs, C. K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-117 · Cited by 117
“Amyloid beta deposition and microglial activation are two major pathophysiologic hallmarks of the progression of Alzheimer’s disease, often suggested to be associated with each other [1-9].”
BackgroundYanguas‐Casás, N., Crespo‐Castrillo, A., de Ceballos, M. L., Chowen, J. A., Azcoitia, I., Arevalo, M. A., & Garcia‐Segura, L. M. (2018) · Glia · doi:10.1002/glia.23263 · Cited by 117
“…dysfunction is a potent contributor to the disease phenotype (Christie, Freeman, & Hyman, 1996; Chung et al., 2015; Doens & Fernandez, 2014; Edmonson, Ziats, & Rennert, 2016; Mead & Ashwood, 2015; Meyer-Luehmann et al., 2008; Paolicelli et al., 2011; Petrelli, Pucci, & Bezzi, 2016; Shatz, 1990).”
Fibril fragmentation in amyloid assembly and cytotoxicity: When size matters
Xue, W.-F., Hellewell, A. L., Hewitt, E. W., & Radford, S. E. (2010) · Prion · doi:10.4161/pri.4.1.11378 · Cited by 117
Ruganzu, J. B., Zheng, Q., Wu, X., He, Y., Peng, X., Jin, H., Zhou, J., Ma, R., Ji, S., Ma, Y., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113506 · Cited by 114
Lau, S.-F., Chen, C., Fu, W.-Y., Qu, J. Y., Cheung, T. H., Fu, A. K. Y., & Ip, N. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107530 · Cited by 114
“The deposition of Ab plaques triggers a microglial response, wherein microglia migrate toward Ab plaques to initiate phagocytosis (Hansen et al., 2018; Meyer-Luehmann et al., 2008).”
BackgroundPluta, R., Furmaga-Jabłońska, W., Maciejewski, R., Ułamek-Kozioł, M., & Jabłoński, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8360-z · Cited by 114
“their growth leading to their steady size after initial formation [101].”
BackgroundPenke, B., Szűcs, M., & Bogár, F. (2020) · Molecules · doi:10.3390/molecules25071659 · Cited by 114
Rodríguez, J. J., Witton, J., Olabarria, M., Noristani, H. N., & Verkhratsky, A. (2010) · Cell Death & Disease · doi:10.1038/cddis.2009.2 · Cited by 114
“Similarly, a recent longitudinal study using multiphoton microscopy to image the brains of 5–6-month-old B6C3-YFP transgenic mice (bearing APPswe and PS1d9xYFP genes) has also alluded to this, reporting that microglia are recruited to Ab plaques only after they have been formed.(33)”
BackgroundThe Non-Core Regions of Human Lysozyme Amyloid Fibrils Influence Cytotoxicity
Mossuto, M. F., Dhulesia, A., Devlin, G., Frare, E., Kumita, J. R., de Laureto, P. P., Dumoulin, M., Fontana, A., Dobson, C. M., & Salvatella, X. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.005 · Cited by 114
ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
Shibuya, Y., Chang, C. C., & Chang, T.-Y. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.161 · Cited by 113
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease
Aytan, N., Choi, J.-K., Carreras, I., Brinkmann, V., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2016) · Scientific Reports · doi:10.1038/srep24939 · Cited by 113
Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer's disease mice
Perusini, J. N., Cajigas, S. A., Cohensedgh, O., Lim, S. C., Pavlova, I. P., Donaldson, Z. R., & Denny, C. A. (2017) · Hippocampus · doi:10.1002/hipo.22756 · Cited by 113
“Bioscience, Minneapolis, MN) 24 h prior to sacrifice to label plaques (Meyer-Luehmann et al., 2008).”
BackgroundMethodMontero, J., Mari, M., Colell, A., Morales, A., Basañez, G., Garcia-Ruiz, C., & Fernández-Checa, J. C. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.010 · Cited by 112
“Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites which appears within days to weeks [49].”
BackgroundElevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia
Zhao, N., Qiao, W., Li, F., Ren, Y., Zheng, J., Martens, Y. A., Wang, X., Li, L., Liu, C.-C., Chen, K., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20212479 · Cited by 111
“Microglial TREM2-GFP expression was induced at birth, and the amyloid plaque was labeled by Methoxy-X04 via intraperitoneal injection prior to imaging (Meyer-Luehmann et al., 2008).”
MethodEvidence for Age-Dependent in Vivo Conformational Rearrangement within Aβ Amyloid Deposits
Nyström, S., Psonka-Antonczyk, K. M., Ellingsen, P. G., Johansson, L. B. G., Reitan, N., Handrick, S., Prokop, S., Heppner, F. L., Wegenast-Braun, B. M., Jucker, M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb4000376 · Cited by 111
A FRET Sensor for Non‐Invasive Imaging of Amyloid Formation in Vivo
Kaminski Schierle, G. S., Bertoncini, C. W., Chan, F. T. S., van der Goot, A. T., Schwedler, S., Skepper, J., Schlachter, S., van Ham, T., Esposito, A., Kumita, J. R., et al. (2011) · ChemPhysChem · doi:10.1002/cphc.201000996 · Cited by 111
Defining the earliest pathological changes of Alzheimer's disease
C. Vickers, J., Mitew, S., Woodhouse, A., M. Fernandez-Martos, C., T. Kirkcaldie, M., J. Canty, A., H. McCormack, G., & E. King, A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151218150322 · Cited by 110
“In vivo imaging studies of FAD transgenic mice show that Aβ plaques can form rapidly and are then relatively stable in morphology [5] and that smaller plaque deposits can occur in clusters and then merge into larger plaques [6].”
BackgroundKell, D. B., & Pretorius, E. (2018) · Biological Reviews · doi:10.1111/brv.12407 · Cited by 110
“The cytotoxicity of amyloids is well known (e.g. Ahmed et al., 2010; Bester et al., 2015; Hefti et al., 2013; Kayed & Lasagna-Reeves, 2013; Liu et al., 2011; Meyer-Luehmann et al., 2008; Minter, Taylor & Crack, 2016; Miranda et al., 2000; Rival et al., 2009; Sengupta, Nilson & Kayed, 2016).”
BackgroundIn vivo dynamics of innate immune sentinels in the CNS
Nayak, D., Zinselmeyer, B. H., Corps, K. N., & McGavern, D. B. (2012) · IntraVital · doi:10.4161/intv.22823 · Cited by 109
Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer's disease
Watts, J. C., Giles, K., Grillo, S. K., Lemus, A., DeArmond, S. J., & Prusiner, S. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019034108 · Cited by 109
“05) and Aβ(1-42) levels were increased approximately eightfold (**P < 0.”
BackgroundMethodInfluentialRAGE: The Beneficial and Deleterious Effects by Diverse Mechanisms of Actions
Han, S.-H., Kim, Y. H., & Mook-Jung, I. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0030-x · Cited by 108
Menopause, obesity and inflammation: interactive risk factors for Alzheimer’s disease
Christensen, A., & Pike, C. J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00130 · Cited by 108
“J., et al. (1995). Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses’ Health Study (United States).”
BackgroundTherapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease
Balendra, V., & Singh, S. K. (2021) · Open Biology · doi:10.1098/rsob.210013 · Cited by 117
“Accumulation of Aβ causes a loss and malformation of spines due to spine turnover in dendrites [52,53], causing characteristic behavioural and cognitive deficits.”
BackgroundInflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products
Rather, M. A., Khan, A., Alshahrani, S., Rashid, H., Qadri, M. M., Rashid, S., Alsaffar, R. M., Kamal, M. A., & Rehman, M. U. (2021) · Mediators of Inflammation · doi:10.1155/2021/9982954 · Cited by 122
“This process of liberation augments the neurotoxic e ff ects of A β and aggravates the pathological processes of AD [161, 163 – 165].”
Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes
Majumdar, A., Capetillo-Zarate, E., Cruz, D., Gouras, G. K., & Maxfield, F. R. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-09-0745 · Cited by 105
Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism
Dhawan, G., Floden, A. M., & Combs, C. K. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.027 · Cited by 104
Cho, H., Hashimoto, T., Wong, E., Hori, Y., Wood, L. B., Zhao, L., Haigis, K. M., Hyman, B. T., & Irimia, D. (2013) · Scientific Reports · doi:10.1038/srep01823 · Cited by 104
Self-citationThe Pathogenesis of Glaucoma in the Interplay with the Immune System
Rieck, J. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9781 · Cited by 105
The impact of glial activation in the aging brain.
Lynch, A. M., Murphy, K. J., Deighan, B. F., O’Reilly, J.-A., Gun’ko, Y. K., Cowley, T. R., González-Reyes, R. E., & Lynch, M. A. (2010) · Europe PMC (PubMed Central) · Cited by 139
Rozkalne, A., Hyman, B. T., & Spires-Jones, T. L. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.014 · Cited by 103
Self-citationOrchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease
Rudinskiy, N., Hawkes, J. M., Betensky, R. A., Eguchi, M., Yamaguchi, S., Spires-Jones, T. L., & Hyman, B. T. (2012) · Nature Neuroscience · doi:10.1038/nn.3199 · Cited by 103
Self-citationMicroglial Activation in Alzheimers Disease
Schlachetzki, J., & Hull, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147179 · Cited by 104
Darwish, S. F., Elbadry, A. M. M., Elbokhomy, A. S., Salama, G. A., & Salama, R. M. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1231706 · Cited by 118
Maheswaran, S., Barjat, H., Rueckert, D., Bate, S. T., Howlett, D. R., Tilling, L. C., Smart, S., Pohlmann, A., Richardson, J. C., Hartkens, T., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.045 · Cited by 121
Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition
Condello, C., Schain, A., & Grutzendler, J. (2011) · Scientific Reports · doi:10.1038/srep00019 · Cited by 102
Bridging the gap: From protein misfolding to protein misfolding diseases
Luheshi, L. M., & Dobson, C. M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.030 · Cited by 111
“journal homepage: www.FEBSLetters .org Minireview Bridging the gap: From protein misfolding to protein misfolding diseases Leila M. Luheshi, Christopher M. Dobson * Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK a r t i c l e i n f o a b s t r a c t Article history: Received 28…”
MethodInfluentialA Dormant Microbial Component in the Development of Preeclampsia
Kell, D. B., & Kenny, L. C. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00060 · Cited by 101
Gallagher, J. J., Minogue, A. M., & Lynch, M. A. (2013) · Neurodegenerative Diseases · doi:10.1159/000337458 · Cited by 100
Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers
Kim, K., Lee, C. H., & Park, C. B. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00107d · Cited by 105
Ahuja, A., Dev, K., Tanwar, R. S., Selwal, K. K., & Tyagi, P. K. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.003 · Cited by 108
Plaque-associated local toxicity increases over the clinical course of Alzheimer disease
Serrano-Pozo, A., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.10.010 · Cited by 100
Self-citationRole of Atypical Chemokine Receptors in Microglial Activation and Polarization
Salvi, V., Sozio, F., Sozzani, S., & Del Prete, A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00148 · Cited by 99
“Other chemokines, such as CCL3, CXCL10 and CCL2 were implicated in the regulation of glial activity involved in neuroinflammation and neurotoxic environment during the AD development (Xia et al., 2000; Galimberti et al., 2006; Meyer-Luehmann et al., 2008; Dos Passos et al., 2016).”
Plescher, M., Seifert, G., Hansen, J. N., Bedner, P., Steinhäuser, C., & Halle, A. (2018) · Glia · doi:10.1002/glia.23318 · Cited by 100
In Vivo Deep-Brain Structural and Hemodynamic Multiphoton Microscopy Enabled by Quantum Dots
Liu, H., Deng, X., Tong, S., He, C., Cheng, H., Zhuang, Z., Gan, M., Li, J., Xie, W., Qiu, P. S., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01708 · Cited by 109
Glial connexin expression and function in the context of Alzheimer's disease
Koulakoff, A., Mei, X., Orellana, J. A., Sáez, J. C., & Giaume, C. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.10.001 · Cited by 110
Heat Shock Protein 90 in Alzheimer’s Disease
Ou, J.-R., Tan, M., Xie, A., Yu, J., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/796869 · Cited by 116
Ahnaou, A., Moechars, D., Raeymaekers, L., Biermans, R., Manyakov, N. V., Bottelbergs, A., Wintmolders, C., Van Kolen, K., Van De Casteele, T., Kemp, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13839-6 · Cited by 98
In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks
Burgold, S., Bittner, T., Dorostkar, M. M., Kieser, D., Fuhrmann, M., Mitteregger, G., Kretzschmar, H., Schmidt, B., & Herms, J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0787-6 · Cited by 98
“[16] which found that plaques appeared very rapidly (within 24 h) and did not change significantly in size thereafter.”
BackgroundResultMagga, J., Puli, L., Pihlaja, R., Kanninen, K., Neulamaa, S., Malm, T., Härtig, W., Grosche, J., Goldsteins, G., Tanila, H., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-90 · Cited by 97
“In the brain parenchyma, the reduction of Ab burden may be endogenously carried out by astroglia [15,16] in addition to microglia, which have been demonstrated to participate in both deposition of Ab [2,17] as well as reduction of Ab burden by phagocytosis or some other mechanisms [18-20].”
BackgroundAnimal models of amyloid‐β‐related pathologies in Alzheimer’s disease
Philipson, O., Lord, A., Gumucio, A., O’Callaghan, P., Lannfelt, L., & Nilsson, L. N. G. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07564.x · Cited by 96
Inflammation in transgenic mouse models of neurodegenerative disorders
Schwab, C., Klegeris, A., & McGeer, P. L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.013 · Cited by 97
AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
Prasad, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03553-4 · Cited by 101
Park, S. H., Kim, J. H., Bae, S. S., Hong, K. W., Lee, D., Leem, J. Y., Choi, B. T., & Shin, H. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.068 · Cited by 103
“Fibrillar amyloid plaques may trigger neuroinflammatory cascades [19].”
BackgroundBoridy, S., Takahashi, H., Akiyoshi, K., & Maysinger, D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.010 · Cited by 103
Han, S., Kollmer, M., Markx, D., Claus, S., Walther, P., & Fändrich, M. (2017) · Scientific Reports · doi:10.1038/srep43577 · Cited by 95
The Effects of NOS2 Gene Deletion on Mice Expressing Mutated Human AβPP
Colton, C. A., Wilcock, D. M., Wink, D. A., Davis, J., Van Nostrand, W. E., & Vitek, M. P. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15405 · Cited by 95
“[93], who show that microglia in the brain of a mouse model of AD rapidly surround newly formed amyloid plaques, mayhap in an effort to wall off these abnormal structures.”
Chuang, J.-Y., Lee, C.-W., Shih, Y.-H., Yang, T., Yu, L., & Kuo, Y.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033120 · Cited by 95
Estes, R., Lin, B. C., Khera, A., & Davis, M. Y. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.788695 · Cited by 109
Amyloid plaque formation precedes dendritic spine loss
Bittner, T., Burgold, S., Dorostkar, M. M., Fuhrmann, M., Wegenast-Braun, B. M., Schmidt, B., Kretzschmar, H., & Herms, J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1047-8 · Cited by 94
“We were especially interested in the chronology: Which event comes first, dendritic spine loss or plaque formation? While a recent study investigated changes of neuritic curvature after plaque appearance [41], we were able to observe the fate of individual dendritic spines not only after the appearance of fibrillar pl…”
BackgroundMethodThe DIADEM Metric: Comparing Multiple Reconstructions of the Same Neuron
Gillette, T. A., Brown, K. M., & Ascoli, G. A. (2011) · Neuroinformatics · doi:10.1007/s12021-011-9117-y · Cited by 95
Mellott, T. J., Pender, S. M., Burke, R. M., Langley, E. A., & Blusztajn, J. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094287 · Cited by 93
Amyloid‐β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease
Sanchez‐Mico, M. V., Jimenez, S., Gomez‐Arboledas, A., Muñoz‐Castro, C., Romero‐Molina, C., Navarro, V., Sanchez‐Mejias, E., Nuñez‐Diaz, C., Sanchez‐Varo, R., Galea, E., et al. (2021) · Glia · doi:10.1002/glia.23943 · Cited by 93
Savonenko, A. V., Melnikova, T., Wang, Y., Ravert, H. T., Gao, Y., Koppel, J. L., Lee, D., Pletniková, O., Cho, E., Sayyida, N., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129618 · Cited by 104
Advances in ion mobility spectrometry–mass spectrometry reveal key insights into amyloid assembly
Woods, L. A., Radford, S. E., & Ashcroft, A. E. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.10.002 · Cited by 108
A β Internalization by Neurons and Glia
Mohamed, A., & Posse de Chaves, E. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/127984 · Cited by 90
Phagocytic Roles of Glial Cells in Healthy and Diseased Brains
Jung, Y.-J., & Chung, W.-S. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.133 · Cited by 89
“Microglia in the CNS have been regarded as the only major phagocytes that mediate the elimination of synapses, apoptotic cells, neu- ral debris, and pathogenic proteins (Tahara et al., 2006; Jana et al., 2008; Meyer-Luehmann et al., 2008; Wang et al., 2015; Pomilio et al., 2016).”
BackgroundInfluentialKwan, A. C., Duff, K., Gouras, G. K., & Webb, W. W. (2009) · Optics Express · doi:10.1364/oe.17.003679 · Cited by 95
“Plaques grow quickly in vivo within 1–3 days to their full size [30,37].”
BackgroundThe missing link in the amyloid cascade of Alzheimer’s disease – Metal ions
Tiiman, A., Palumaa, P., & Tõugu, V. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.023 · Cited by 104
Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
Guan, Y., & Han, F. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00037 · Cited by 84
“One of the pathological hallmarks of neurodegenerative diseases is the aggregation of abnormal protein in the central nervous system (CNS).”
BackgroundInfluentialMoya, G. E., Rivera, P. D., & Dittenhafer‐Reed, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137030 · Cited by 91
Inside Alzheimer brain with CLARITY: senile plaques, neurofibrillary tangles and axons in 3-D
Ando, K., Laborde, Q., Lazar, A., Godefroy, D., Youssef, I., Amar, M., Pooler, A., Potier, M.-C., Delatour, B., & Duyckaerts, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1322-y · Cited by 86
Linnartz, B., Wang, Y., & Neumann, H. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/587463 · Cited by 87
“Additionally, within one week after the onset of plaque formation dysmorphic neurites were present [11].”
Background
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.